Editorial: Unravelling real‐world impact of second‐line therapies in primary biliary cholangitis—Time to change our targets? Authors' reply

Ähnliche Einträge

• Editorial: Unravelling real‐world impact of second‐line therapies in primary biliary cholangitis— Time to change our targets?
  von: Guilherme Grossi Lopes Cançado
  Veröffentlicht: (2024)
• Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
  von: Lukas Burghart, et al.
  Veröffentlicht: (2024)
• The overlap with metabolic dysfunction‐associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis
  von: María Hernández‐Pérez, et al.
  Veröffentlicht: (2024)
• Editorial: Are changes in quantitative biliary metrics the first sign of progression in primary sclerosing cholangitis?
  von: John E. Eaton, et al.
  Veröffentlicht: (2024)
• Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
  von: Jessica A. Fitzpatrick, et al.
  Veröffentlicht: (2024)